IMMUNOTHERAPEUTIC FORMULATIONS TO GENERATE AUTOANTIBODIES CAPABLE TO AVOID THE BINDING OF INTERLEUKIN-2 TO ITS RECEPTOR.THEIR USE IN THE TREATMENT OF CANCER

THE PRESENT INVENTION IS RELATED TO PHARMACEUTICAL COMPOSITIONS BASED ON VACCINES AND MONOCLONAL ANTIBODIES THAT NEUTRALIZE THE INTERLEUKIN-2, WHICH ARE USEFUL IN THE TREATMENT OF TUMORS. PARTICULARLY THE PRESENT INVENTION IS RELATED TO THERAPEUTIC FORMULATIONS ABLE TO INCREASE THE IMMUNOGENICITY OF...

Full description

Saved in:
Bibliographic Details
Main Authors LIVÁN BLADIMIR ALONSO SARDUY, ROLANDO PÉREZ RODRÍGUEZ, AGUSTÍN BIENVENIDO LAGE DÁVILA, JOSÉ ENRIQUE MONTERO CASIMIRO
Format Patent
LanguageEnglish
Published 31.05.2017
Subjects
Online AccessGet full text

Cover

Loading…